Cinitapride Tartrate/Omeprazole

酒石酸西尼必利/奥美拉唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCinitapride Tartrate/Omeprazole
Drug Alias Name奥美拉唑/酒石酸西尼必利Cinitapride Tartrate and OmeprazoleCinitapride/OmeprazoleOmeprazole/CinitaprideOmeprazole/Cinitapride Tartrate +[7] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsSerotonin 4 (5-HT4) receptor agonists +[4] 
TargetsSerotonin 2 (5-HT2) receptorProton pumpSerotonin 4 (5-HT4) receptor +[4] 
Therapy Area/IndicationsDyspepsiaStomach UlcerGastroesophageal Reflux
Global Approved IndicationsDyspepsiaStomach UlcerGastroesophageal Reflux
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2010/01/01
Country/TerritoryIndia
CombinationsYes Cinitapride TartrateOmeprazole
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila
Inactive CompaniesN/A
Active IndicationsDyspepsiaStomach UlcerGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeA02B
Related LinksN/A